Traditional Prostate Cancer Risks Fail to Predict Hormone Therapy Benefit
Traditional pathological risk factors after prostate cancer surgery successfully identify patients with aggressive disease and worse prognoses, but they fail to predict who will benefit from adding hormone therapy to ... Read More